| scholarly article | Q13442814 |
| P2093 | author name string | Yan Wang | |
| Ze-Hong Miao | |||
| Jia-Xin Li | |||
| Ying-Qing Wang | |||
| P2860 | cites work | Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide | Q24302071 |
| Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components | Q26825621 | ||
| Newly discovered angiogenesis inhibitors and their mechanisms of action | Q26998498 | ||
| Detecting metabolites of different transition metal-lithospermate B complexes after intravenous injection in rats | Q28389748 | ||
| Purification and characterization of hypoxia-inducible factor 1 | Q28678375 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia | Q30399006 | ||
| Therapeutic modulators of STAT signalling for human diseases | Q33684732 | ||
| The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis | Q34316079 | ||
| A signal transducer and activator of transcription 3·Nuclear Factor κB (Stat3·NFκB) complex is necessary for the expression of fascin in metastatic breast cancer cells in response to interleukin (IL)-6 and tumor necrosis factor (TNF)-α | Q34396993 | ||
| Drug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction | Q35128174 | ||
| Dual targeting of microtubule and topoisomerase II by α-carboline derivative YCH337 for tumor proliferation and growth inhibition | Q35832271 | ||
| The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury | Q36179559 | ||
| Marine-derived angiogenesis inhibitors for cancer therapy | Q36994177 | ||
| Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent | Q37230783 | ||
| MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition. | Q37293931 | ||
| Tanshinone-1 induces tumor cell killing, enhanced by inhibition of secondary activation of signaling networks | Q37357080 | ||
| Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. | Q37827709 | ||
| Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms | Q37978125 | ||
| Interleukin-6: an angiogenic target in solid tumours. | Q38136860 | ||
| Inflammation amplifier, a new paradigm in cancer biology | Q38173304 | ||
| Revisiting STAT3 signalling in cancer: new and unexpected biological functions | Q38262473 | ||
| Transcription factor c-Jun activation represses mdr-1 gene expression. | Q38351649 | ||
| Natural product triptolide mediates cancer cell death by triggering CDK7-dependent degradation of RNA polymerase II. | Q39290009 | ||
| c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner | Q39801995 | ||
| Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways | Q40399370 | ||
| Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. | Q40460041 | ||
| Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules | Q46513225 | ||
| Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation | Q47745076 | ||
| Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model. | Q54319778 | ||
| Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro | Q67665202 | ||
| Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial | Q88123697 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| phosphorylation | Q242736 | ||
| tumor angiogenesis | Q110495869 | ||
| P304 | page(s) | 16031-16042 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells | |
| P478 | volume | 6 |
| Q36332681 | A promising "TRAIL" of tanshinones for cancer therapy |
| Q36958382 | BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2. |
| Q47148987 | Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cells |
| Q39216218 | Diterpenes and Their Derivatives as Potential Anticancer Agents |
| Q42512424 | Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells |
| Q54123249 | Qiliqiangxin attenuates hypoxia-induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF-1α-dependent glycolysis. |
| Q52561276 | Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics. |
| Q91779192 | Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway |
| Q50129481 | Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells in vitro and in vivo |
| Q64093119 | Tanshinones, Critical Pharmacological Components in |
| Q42025605 | Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. |
| Q88883453 | Targeting VEGF/VEGFRs Pathway in the Antiangiogenic Treatment of Human Cancers by Traditional Chinese Medicine |
| Q37034926 | The anti-angiogenic effect and novel mechanisms of action of Combretastatin A-4 |
| Q42366665 | The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. |
| Q57813339 | YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells |
Search more.